1,449 results on '"Anand, Sonia S."'
Search Results
2. Sociodemographic factors associated with vaccine hesitancy in the South Asian community in Canada
3. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
4. Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review
5. Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease
6. Early sex-dependent differences in metabolic profiles of overweight and adiposity in young children: a cross-sectional analysis
7. Indigenizing Cardiac Rehabilitation: The Role for Cultural Adaptation
8. Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
9. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation
10. Identifying the highest risk vascular patients: Insights from the XATOA registry
11. The association of maternal sugary beverage consumption during pregnancy and the early years with childhood sugary beverage consumption
12. Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry
13. Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD
14. Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD
15. Consistent cord blood DNA methylation signatures of gestational age between South Asian and white European cohorts
16. Individual- and supply-level macronutrient intakes are well correlated over a 50-year period (1961–2011) in 18 countries in Asia, North America, and Europe
17. Abstract 16428: Impact of Low-Dose Rivaroxaban Plus Aspirin on Myocardial Infarction in Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
18. Abstract 16398: Impact of Low-Dose Rivaroxaban Plus Aspirin on Total Vascular Events in Fragile Patients With Peripheral Artery Disease: Insights From VOYAGER PAD
19. Abstract 14729: Association of Iliac Artery Non-Calcified Plaque Volume and Acute Limb Ischemia: Insights From the VOYAGER PAD Angiographic Core Lab
20. Integrative multiomics analysis of infant gut microbiome and serum metabolome reveals key molecular biomarkers of early onset childhood obesity
21. Changes in energy, macronutrient, and food consumption in 47 countries over the last 70 years (1950-2019): a systematic review and meta-analysis
22. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
23. Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
24. Managing greenhouse gas emissions in the terminal year of life in an overwhelmed health system: a paradigm shift for people and our planet
25. Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD
26. Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort
27. Author Correction: Identification of genetic effects underlying type 2 diabetes in South Asian and European populations
28. DNA methylation changes in cord blood and the developmental origins of health and disease – a systematic review and replication study
29. Identification of genetic effects underlying type 2 diabetes in South Asian and European populations
30. Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study
31. Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease
32. Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making
33. Building Your Peripheral Artery Disease Toolkit: Medical Management of Peripheral Artery Disease in 2022
34. Diet and Nutrition in Peripheral Artery Disease: A Systematic Review
35. Social Deprivation and Peripheral Artery Disease
36. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
37. Bonding social capital and health within four First Nations communities in Canada: A cross-sectional study
38. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD
39. Nutritional Metabolomics and the Classification of Dietary Biomarker Candidates: A Critical Review
40. Maternal smoking DNA methylation risk score associated with health outcomes in offspring of European and South Asian ancestry
41. Engaging Participants Through Hybrid Community-Centered Approaches: Lessons Learned During the COVID CommUNITY Public Health Research Program
42. Getting a “SMART START” to gestational diabetes mellitus education: a mixed-methods pilot evaluation of a knowledge translation tool in primary care
43. COVID-19 vaccine effectiveness among South Asians in Ontario: A test-negative design population-based case-control study
44. Indigenizing Cardiac Rehabilitation: The Role for Cultural Adaptation
45. Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial
46. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
47. Effectiveness of programs aimed at obesity prevention among Indigenous children: A systematic review
48. Abstract 12197: Causes of Death in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization: Insights From Voyager Pad
49. Abstract 10889: Unplanned Limb Revascularization With Rivaroxaban versus Placebo in Patients With Critical Limb Ischemia After Endovascular and Surgical Treatment: Insights From Voyager Pad
50. Abstract 10240: Lower May Not Be Better: Systolic Blood Pressure and Risk of Major Adverse Limb Events in Patients With Symptomatic Peripheral Artery Disease After Revascularization: Insights From Voyager Pad
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.